Kristen Ludgate - Dec 8, 2022 Form 4 Insider Report for HP INC (HPQ)

Role
Chief People Officer
Signature
/s/ Rick Hansen as Attorney-in-Fact for Kristen Ludgate
Stock symbol
HPQ
Transactions as of
Dec 8, 2022
Transactions value $
$0
Form type
4
Date filed
12/12/2022, 07:18 PM
Previous filing
Dec 9, 2022
Next filing
Jul 14, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HPQ Restricted Stock Units Award +47.2K 47.2K Dec 8, 2022 Common Stock 47.2K Direct F1, F2
transaction HPQ Performance Adjusted Restricted Stock Units Award +30.2K 30.2K Dec 8, 2022 Common Stock 30.2K Direct F3, F4
transaction HPQ Performance Contingent Stock Options Award +107K 107K Dec 8, 2022 Common Stock 107K $28.48 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.
F2 On 12/8/2022, the reporting person was granted 47,191 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock.
F3 Each performance adjusted restricted stock unit ("PARSU") represents a contingent right to receive one share of HP common stock.
F4 On 12/8/2022, the reporting person was granted 30,191 PARSUs, which will only be earned after certification of financial results as of October 31, 2025, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Depending on the level of achievement of such goals, the actual number of PARSUs earned can range from 0% to 300% of the target number of PARSUs shown in column 5. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock.
F5 On 12/8/2022, the reporting person was granted 106,864 performance contingent stock options, 1/3 of which vest annually over 3 years on the anniversary of the grant date, in each case subject to the satisfaction of certain stock price performance conditions.